The lifeblood of the U.S. industry’s trade action against Chinese extruders is the energy of its members. That energy manifests itself as action, communication, and financial participation. By the end of 2013 the industry had invested over $5.5 million in legal fees and other costs associated with winning, and subsequently defending this case since the process began in late 2009. This investment has gone to winning the original petition, fighting off a major court decision referred to as GPX, dozens of scope requests and appeals, the first annual administrative review, and a substantial down payment on the second annual administrative review. As 2014 takes shape it is clear that this battle will continue to rage. I want to lay out the costs, and present our 2014 funding strategy.